alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1


                                                                    EXHIBIT 23.0


                         CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in this Annual Report (Form 10-K)
of Cooper Industries, Inc. of our report dated January 25, 1999, included in
Appendix A to the Cooper Industries, Inc. Proxy Statement for the 1999 Annual
Meeting of Shareholders.

We also consent to the incorporation by reference in the following Registration
Statements on Form S-8 or Form S-3 of Cooper Industries, Inc. and in each
related Prospectus of our report dated January 25, 1999, with respect to the
consolidated financial statements incorporated herein by reference.

Registration
Statement No.                           Purpose

No. 2-71732       Form S-8 Registration Statement for Shares issuable pursuant 
                  to Substitute Deferred Compensation Agreements in connection
                  with the acquisition of Crouse-Hinds Company

No. 2-33-14542    Form S-8 Registration Statement for Cooper Industries, Inc.
                  1985 and 1989 Employee Stock Purchase Plans

No. 2-33-19574    Form S-8 Registration Statement for Cooper Industries, Inc. 
                  1986 Stock Option Plan

No. 2-33-29302    Form S-8 Registration Statement for 1989 Director Stock 
                  Option Plan

No. 33-57829      Form S-8 Registration Statement for Cooper Industries, Inc. 
                  1986 Stock Option  Plan

No. 333-02847     Form S-8 Registration Statement for Cooper Industries, Inc. 
                  Directors' Stock Plan

No. 333-08277     Form S-8 Registration Statement for Cooper Industries, Inc. 
                  Stock Incentive Plan

No. 333-24237     Form S-3 Registration Statement for Cooper Industries, Inc. 
                  Dividend Reinvestment and Stock Purchase Plan

No. 333-51439     Form S-8 Registration Statement for Cooper Industries, Inc. 
                  Director's Retainer Fee Stock Plan

No. 333-51441     Form S-8 Registration Statement for Cooper Industries, Inc. 
                  Amended and Restated Management Annual Incentive Plan

                                                     /s/ ERNST & YOUNG LLP

Houston, Texas
March 30, 1999
#### Olive Rose LOVELL, Appellant, v. Mary Baker HENRY and Carl D. Baker, Appellees.

No. 67-948.

District Court of Appeal of Florida. Third District.

June 11, 1968.

Rehearing Denied July 24, 1968.

*68Kelner & Lewis, Miami, for appellant.

Hawkesworth & Kay, Miami, for ap-pellees.

Before BARKDULL and HENDRY, JJ., and SPECTOR, SAM, Associate Judge.

PER CURIAM.

Plaintiff in a personal injuries action arising from an automobile accident appeals from a final judgment of $3,000 entered pursuant to a jury verdict. The point urged by appellant for reversal is the trial court’s refusal to grant plaintiff’s motion for mistrial which motion was made during the course of defense counsel’s summation before the jury.

The particular conduct of defense counsel on which appellant grounded her motion for mistrial was the use by said defense counsel of a doctor’s report to refresh his memory during the course of his summation of the case before the jury. Appellant contends that the doctor’s report, which had not been admitted into evidence, was alluded to by defense counsel as if it were actually in evidence; and, further, that the said report contained notes written in large, red letters calculated to influence the jury when observed by its members. In refusing to grant plaintiff’s motion for mistrial, the trial judge manifested his belief that the doctor’s report was not alluded to in the fashion complained of and, further, that the notes written on the report were not such, nor were they used in a manner so as to have the effect on the jury about which plaintiff complained. Our review of the record leads us to conclude that the trial judge was correct in this regard.

It is well settled that counsel is accorded a wide latitude in making his argument to a jury. Whether the bounds of propriety in such regard have been exceeded, however, must be measured against the prejudicial effect, if any, that is likely to be had upon the jury. Schnedl v. Rich, 137 So.2d 1 (Fla.App.2d 1962). Jury arguments will not be considered grounds for mistrial unless they are highly prejudicial and inflammatory. H. I. Holding Company v. Dade County, 129 So.2d 693 (Fla.App.3d 1961).

No showing having been made that the conduct complained of in the case at bar is prejudicial or inflammatory, the judgment appealed is therefore

Affirmed.

BARKDULL, J., dissents.
Exhibit 10.74
 AMENDMENT NO. 1
 TO
 SEVERANCE AGREEMENT (NON-CHANGE IN CONTROL)
 
    1.
    
    Amendment to Section 6.2, Non-Solicitation. Section 6.2 of the Agreement is
hereby amended in its entirety so as to read as follows:6.2 Non-Solicitation.The Executive agrees that during the Executives employment
and at all times thereafter during the Severance Period, the Executive will not,
directly or indirectly, individually or on behalf of any other person, firm,
corporation or other entity, knowingly solicit, aid or induce any employee of the
Employer to leave such employment in order to accept employment with or render services
to or with any other person, firm, corporation or other entity unaffiliated with the
Employer or knowingly take any action to materially assist or aid any other person,
firm, corporation or other entity in identifying or hiring any such employee.
 2.
    
    Amendment to Section 6.4, Competition. Section 6.4 of the Agreement is hereby
amended in its entirety so as to read as follows:6.4 [Intentionally Deleted]3.
    
    No Other Amendments. Except as expressly amended hereby, the Agreement remains
in full force and effect.
 [NAME OF EMPLOYER]
    
    
    
    EXECUTIVEBy:
    
    
    
    
    
    By:Name:
    
    
    
    
    
    Name:Title:
    
    
    
    
    
    Address:
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>           UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE 
CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN ITEM 8 OF CONSOLIDATED
NATURAL GAS COMPANY'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER
31, 1995, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL 
STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-START>                  JAN-01-95
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               DEC-31-1995
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                    2,924,121
<OTHER-PROPERTY-AND-INVEST>                    988,284
<TOTAL-CURRENT-ASSETS>                       1,068,661
<TOTAL-DEFERRED-CHARGES>                       347,616
<OTHER-ASSETS>                                  89,611
<TOTAL-ASSETS>                               5,418,293
<COMMON>                                       257,377
<CAPITAL-SURPLUS-PAID-IN>                      438,255
<RETAINED-EARNINGS>                          1,309,906
<TOTAL-COMMON-STOCKHOLDERS-EQ>               2,045,818
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<LONG-TERM-DEBT-NET>                         1,291,811
<SHORT-TERM-NOTES>                                   0
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                 336,000
<LONG-TERM-DEBT-CURRENT-PORT>                   10,250
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>               1,734,414
<TOT-CAPITALIZATION-AND-LIAB>                5,418,293
<GROSS-OPERATING-REVENUE>                    3,307,325
<INCOME-TAX-EXPENSE>                             2,943
<OTHER-OPERATING-EXPENSES>                   3,157,869
<TOTAL-OPERATING-EXPENSES>                   3,160,812
<OPERATING-INCOME-LOSS>                        146,513
<OTHER-INCOME-NET>                             (20,506)
<INCOME-BEFORE-INTEREST-EXPEN>                 126,007
<TOTAL-INTEREST-EXPENSE>                       104,663
<NET-INCOME>                                    21,344
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                   21,344
<COMMON-STOCK-DIVIDENDS>                       181,055
<TOTAL-INTEREST-ON-BONDS>                       97,515
<CASH-FLOW-OPERATIONS>                         552,724
<EPS-PRIMARY>                                      .23<F1>
<EPS-DILUTED>                                      .23<F1>
<FN>
<F1>  RESTATED TO REFLECT THE ADOPTION OF STATEMENT OF FINANCIAL
      ACCOUNTING STANDARDS NO. 128, "EARNINGS PER SHARE."
</FN>
        

</TABLE>
```

[Federal Register Volume 83, Number 151 (Monday, August 6, 2018)]
[Notices]
[Pages 38299-38300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16750]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER18-2091-000]

Titan Solar, LLC; Supplemental Notice That Initial Market-Based 
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding of 
Titan Solar, LLC's application for market-based rate authority, with an 
accompanying rate tariff, noting that such application includes a 
request for blanket authorization, under 18 CFR part 34, of future 
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street NE, Washington, 
DC 20426, in accordance with Rules 211 and 214 of the Commission's 
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone 
filing a motion to intervene or protest must serve a copy of that 
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability, is August 20, 2018.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
5 copies

[[Page 38300]]

of the intervention or protest to the Federal Energy Regulatory 
Commission, 888 First Street NE, Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for electronic review in the 
Commission's Public Reference Room in Washington, DC. There is an 
eSubscription link on the website that enables subscribers to receive 
email notification when a document is added to a subscribed docket(s). 
For assistance with any FERC Online service, please email 
[email protected]. or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.

    Dated: July 31, 2018.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2018-16750 Filed 8-3-18; 8:45 am]
 BILLING CODE 6717-01-P
```
# 2017 NAPCS
II 

113TH CONGRESS 

2D SESSION S. 1902 

To require notification of individuals of breaches of personally identifiable 

information through Exchanges under the Patient Protection and Affordable Care Act. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 9, 2014 

Mr. BARRASSO (for himself, Mr. JOHANNS, Mr. COBURN, Mr. COCHRAN, Mr. 

ISAKSON, Mr. MORAN, Mr. HATCH, Mrs. FISCHER, Mr. SCOTT, and Mr. 

BURR) introduced the following bill; which was read twice and referred 

to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To require notification of individuals of breaches of personally identifiable information through Exchanges under 

the Patient Protection and Affordable Care Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Exchange Secu5 rity and Transparency Act of 2014’’. 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 1902 IS

1 SEC. 2. NOTIFICATION OF INDIVIDUALS OF BREACHES OF 

2 PERSONALLY IDENTIFIABLE INFORMATION 

3 THROUGH PPACA EXCHANGES. 

4 Not later than two business days after the discovery 

5 of a breach of security of any system maintained by an 

6 Exchange established under section 1311 or 1321 of the 

7 Patient Protection and Affordable Care Act (42 U.S.C. 

8 18031, 18041) which is known to have resulted in person9 ally identifiable information of an individual being stolen 

10 or unlawfully accessed, the Secretary of Health and 

11 Human Services shall provide notice of such breach to 

12 each such individual. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 31, 2018. Such persons may also file a written request for a hearing on the application on or before August 31, 2018.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 4, 2018, Ultra Scientific Inc., 250 Smith Street, North Kingstown, Rhode Island 02852 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance
Drug 
                             code
ScheduleMarihuana
7360
ITetrahydrocannabinols
7370
I
 The company plans to import derivatives of the listed controlled substances for use as chemical standards for testing and calibration only of analytical equipment. The above controlled substances will not be imported for human or animal consumption. Dated: July 23, 2018. John J. Martin, Assistant Administrator.


[FR Doc. 2018-16465 Filed 7-31-18; 8:45 am] BILLING CODE 4410-09-P
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

ALANAH F.F. PETERS,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 101 EAL 2018

Petition for Allowance of Appeal from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 30th day of August, 2018

, the Petition for Allowance of Appeal is

GRANTED

, LIMITED TO the issue set forth below. Allocatur is DENIED as to all

remaining issues. The issue, rephrased for clarity, is:

Whether the Superior Court erred in rejecting, und er a constructive possession theory, Petitioner’s challenge to the sufficiency of the evidence to support her conviction for carrying a firearm without a license?
SERVED: MARCH 4, 2015 U.S. DEPARTMENT OF TRANSPORTATION OFFICE OF HEARINGS

WASHINGTON, DC IN THE MATTER OF WORLD LOGISTICS SOLUTIONS, LLC DOCKETNO. FAA-2015-0207 (Civil Penalty Action)
NOTICE OF ASSIGNMENT OF PROCEEDING**~-~**T 

### r.____ _ ··- . ... n ; __ . ·:

Thisproceeding (heretofore designated as Case No. 2014-GL-70-0263) has been assigned to Administrative Law Judge Richard C. Goodwin. All future pleadings and other communications regarding this proceeding shall be served onthe Judge, the FAA Hearing Docket, and the otherpersons on the attached Service List.

Attachment
- Service List

# --------------------------

# ...................

SERVICE LIST -BY U.S. MAIL ' ORIGINAL & ONE COPY 

### Federal Aviation Administration 800 Independence Avenue, S.W. Washington, DC 20591 Attention: Hearing Docket Clerk, AGC-430 Wilbur Wright Building-Suite 2WI

# ooo 1

/ 

### Amielina Elhassani, Principal Viabox, Respondent 

### 25883 N Park Avenue Elkhart, IN 46514 Kate Barber, Complainant's Counsel 

### Office ofRegional Counsel Federal Aviation Administration 2300 East Devon Avenue, AGL-7 Des Plaines, IL 60018-4696 TEL: 847-294-7862 FAJ<: 847-294-7498 ONE COPY



### The Honorable Richard C. Goodwin,Administrative LawJudge 

### Office ofHearings, M-20 U.S. Department ofTransportation 1200 NewJersey Avenue, S.E. (Ell-310) Washington, DC 20590 TEL: 202-366-5121 StaffAssistant FAJ<: 202-366-7536 DocketNo. FAA-2015-0207 (Civil Penalty Action)

1 Service was by U.S. Mail. For service in person orby expedited courier, use the following address: Federal Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building-Suite 2WIOOO, Washington, DC 20591; Attention: Hearing Docket Clerk, AGC-430. 4
**Exhibit 10.30**

 

**FIRST AMENDMENT TOEMPLOYMENT AGREEMENT**

*** ***

***Kim S. Brace***

 

 

This First Amendment to Employment Agreement(“Amendment”) is made as of April 22, 2003, between PACIFIC NORTHWESTBANCORP and its subsidiary, PACIFIC NORTHWEST BANK (individually and collectivelyreferred to as “Bank”) and KIM S. BRACE (“Executive”), who agree as follows:

 

1.         Extension. Bank has requested Executive, and Executive has agreed to extend theterm of her Employment Agreement with Bank dated as of June 15, 2001 (the“Employment Agreement”) for an additional two years to June 15, 2005.  The second sentence of Section 2 of theEmployment Agreement is amended and revised to read as follows:

 

The term of thisAgreement begins on June 16, 2001, and terminates on June 15, 2005(“Term”).

 

2.         Health Care Insurance Coverage.  In addition to any severance or otherpayments due to Executive pursuant to the Employment Agreement, Bank shall pay all premiums for thecontinuation of health care coverage benefits to Executive and her covered spouseand dependents pursuant to the Consolidated Omnibus Budget Reconciliation Act(COBRA) for a period of up to eighteen (18) months after the termination ofExecutive’s employment with Bank or itssuccessor (including employment with any parent company or subsidiary undercommon control with Bank or its successor) other than a termination forCause in the event that either: (a) a Change of Control (as defined inBank’s Change of Control Agreements with certain other key executives) occursand Executive does not continue to be employed by Bank or its successor(including employment with any parent company or subsidiary under commoncontrol with Bank or its successor) for more than thirty (30) months after theclosing of the transaction, or (b) upon the retirement of Executive if, onthe date of retirement, Executive is at least sixty (60) years of age and hasbeen employed by Bank and/or its successor(including employment with any parent company or subsidiary under commoncontrol with Bank or its successor) for at least five (5) years.

 

3.         Except as expressly modified hereby, the terms andprovisions of the Employment Agreement shall continue and remain in full forceand effect.

 

----
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

No. PD-1598-06

RICHARD ROBLES VIGIL, Appellant

v.

THE STATE OF TEXAS

ON STATE’S PETITION FOR DISCRETIONARY REVIEW

FROM THE FOURTEENTH COURT OF APPEALS

HARRIS COUNTY

Per curiam.

O P I N I O N

Appellant was placed on deferred adjudication probation and guilt was later

adjudicated and Appellant was convicted of indecency with a child. Appellant attempted to

appeal the adjudication of guilt arguing that the trial court erred in not sua sponte holding a

hearing on his competency. The Court of Appeals dismissed, finding that there was no

jurisdiction to consider the issue pursuant to Code of Criminal Procedure Article 42.12,

§5(b). Vigil v. State, No. 14-05-01015-CR (Tex. App.–Houston [14th], July 13, 2006).

Appellant petitioned this Court for discretionary review.
2

When the Court of Appeals issued its opinion in this case, it did so without the benefit

of this Court’s recent opinion in Durgan v. State, ___ S.W.3d ___, No. PD-1069-06 (Tex.

Crim. App. November 7, 2007). Therefore, we vacate the judgment of the Court of Appeals

and remand for that court to consider the effect of Durgan, if any, on its reasoning and

analysis in this case.

En banc

Delivered: February 6, 2008

Do Not Publish